ASND
Ascendis Pharma A/S
$264.92
+0.53% (+$1.41)
Volume
406,041
52W High
$282.15
52W Low
$186.05
Market Cap
$13.75B
Next Earnings Report
Last Reported
Aug 13, 2026 Beat
Actual: $3.29
vs. Consensus: $0.78
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q2 2026
Aug 13, 2026
1-Day:
+0.92%
5-Day:
+1.06%
Q2 2026
Aug 6, 2026
1-Day:
+2.23%
5-Day:
+1.89%
Q1 2026
May 7, 2026
1-Day:
-3.04%
5-Day:
-3.45%
Q1 2026
Apr 30, 2026
1-Day:
-3.68%
5-Day:
-1.79%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $245.2M | +41.0% | 88.9% | 4.0% | -$33.2M |
| Q3'25 | $213.6M | +269.4% | 89.5% | 5.2% | -$61.0M |
| Q2'25 | $158.0M | +339.0% | 80.1% | -33.5% | -$38.9M |
| Q1'25 | $101.0M | +5.3% | 82.7% | -103.2% | -$94.6M |
| Q4'24 | $173.9M | +26.3% | 91.9% | 0.2% | -$38.5M |
| Q3'24 | $57.8M | +20.4% | 80.6% | -167.3% | -$99.2M |
| Q2'24 | $36.0M | -24.0% | 68.2% | -370.2% | -$109.4M |
| Q1'24 | $95.9M | +185.5% | 92.1% | -51.3% | -$131.0M |
Company Information
Symbol
ASND
Company
Ascendis Pharma A/S
Market Cap
$13.75B